There are 3397 resources available
2390P - Correlation between overall survival and bladder-intact event-free survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden
Presenter: Kelvin Kwok
Session: Poster session 24
2391P - Impact of perioperative chemotherapy on survival and pathological stage in muscle-invasive micropapillary urothelial bladder cancer
Presenter: Arya Mariam Roy
Session: Poster session 24
2393P - Ephrin signalling mediates resistance to programmed death ligand 1 (PD-L1) inhibition in urothelial carcinoma (UC)
Presenter: Yu-Hsuen Yang
Session: Poster session 24
2394P - Biomarkers of treatment (Tx)-related toxicity in advanced urothelial carcinoma (aUC) pts treated with enfortumab vedotin (EV): Analysis of UNITE study
Presenter: Amanda Nizam
Session: Poster session 24
2395P - Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC)
Presenter: Akshay Sood
Session: Poster session 24
2396P - Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with advanced urothelial cancer
Presenter: Benjamin Miron
Session: Poster session 24
2398P - Are fibroblast growth factor receptor 3 (FGFR3) alterations a possible predictive factor for platinum-based chemotherapy and immunotherapy in metastatic urothelial carcinoma (MUC)?
Presenter: Laura Ferrer-Mileo
Session: Poster session 24